Synonyms: CD37-SMIP [8] | TRU-016 | TRU016
Compound class:
Antibody
Comment: Otlertuzumab (TRU-016) is a monospecific, humanized anti-CD37 antibody-like protein that is being investigated as a clinical therapeutic for various form of lymphoma [4,6-7]. Otlertuzumab was developed using Aptevo's modular ADAPTIRTM platform.
|
Classification | |
Compound class | Antibody |
International Nonproprietary Names | |
INN number | INN |
9832 | otlertuzumab |
Synonyms | |
CD37-SMIP [8] | TRU-016 | TRU016 |
Database Links | |
Specialist databases | |
IMGT/mAb-DB | 488 |
Other databases | |
ChEMBL Ligand | CHEMBL3039539 |
GtoPdb PubChem SID | 374883838 |
Search PubMed clinical trials | otlertuzumab |
Search PubMed titles | otlertuzumab |
Search PubMed titles/abstracts | otlertuzumab |